55% of HME respondents say mask selection is the biggest challenge during remote CPAP setups in a recent survey SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed ...
The incoming AdvaMed chair talked about updates to Resmed’s products and how the company is handling competitive dynamics and ...
The latest update on Wednesday morning shows ResMed shares down by 0.02%, trading at $246.16. At this price, Farrell's 11,442 ...
High-rolling investors have positioned themselves bullish on ResMed (NYSE:RMD), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...
Financial giants have made a conspicuous bearish move on ResMed. Our analysis of options history for ResMed (NYSE:RMD) revealed 10 unusual trades. Delving into the details, we found 20% of traders ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea ...
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...
Jan 16 (Reuters) - ResMed (RMD.N), opens new tab said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the ...
Pre-earnings options volume in ResMed (RMD) is 3.5x normal with puts leading calls 7:5. Implied volatility suggests the market is anticipating a move near 6.9%, or $16.63, after results are released.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback